Latest corporate filings — Indian listed companies
11463 filings processed. AI-summarised within seconds of being filed on BSE/NSE.
All
Financial Results
Dividend
Board Meeting
Insider Trading
Corporate Action
Management Change
Merger / Acquisition
IPO / Listing
Buyback
Credit Rating
-
Outcome of the Board Meeting held on July 23, 2026.
Financial ResultsQ1FY27 results (unaudited): Standalone: Revenue 26.2bn +0.3% y-y (26.2bn) PAT 1.6bn +193% y-y (0.5bn) Consolidated: Revenue 28.4bn -5.6% y-y (30.0bn)… -
Intimation under Regulation 30 of the SEBI (LODR) Regulations, 2015
Management ChangeGovernment appointed Shri J.V.N Subramanyam as Nominee Director on IREDA Board with immediate effect until three Functional Directors are appointed or… -
Intimation of Investor Day
General UpdateInvestor/analyst meet scheduled for 25-Aug-2026 in Mumbai -
Monitoring Agency Report for the quarter ended June 30, 2026
Regulatory ComplianceMonitoring Agency Report for quarter ended June 30, 2026 confirms no deviation in utilization of Rights Issue proceeds. Total proceeds Rs 446.95 crore… -
Intimation of Schedule of Analyst and Institution Investor Meet- Revision in Timings of the Meet.
General UpdateQ1FY27 earnings call rescheduled to 28 July 2026 at 9:30 AM IST -
Intimation w.r.t press release
Financial ResultsPress Release - Q1FY27 - NMV grew 34% YoY to ₹11,614 crore; Marketplace Revenue up 48% YoY to ₹3,707 crore - Annual Transacting Users rose 29% YoY to … -
Press release titled Coromandel International Limited posts Q1 FY27 Results
Financial ResultsPress Release - Q1FY27 - Standalone revenue 7,792 Cr +10% y-y; EBITDA 626 Cr -15% y-y; PAT 377 Cr -26% y-y - Consolidated revenue 8,215 Cr +15% y-y; E… -
Please find enclosed the transcript of the earnings call held on July 22, 2026
Financial ResultsAI summary - NAM India was fastest growing AMC in Top-10 on overall and equity AUM in Q1 FY27 - Market share reached 9.04%, highest since June 2019; e… -
Investor Presentation -Q1 FY 27
Financial ResultsAI summary - Cyient Group Q1 FY27 revenue $219M (+9.5% YoY $ basis), EBIT margin 9.7% - DET EBIT margin improved to 13.2%, PAT margin steady at 9.1% -… -
Intimation w.r.t Shareholders'' letter
Financial ResultsPress Release - Q1 FY27 - Annual Transacting Users grew 29% YoY to 274 million; Quarterly Placed Orders rose 29% YoY to 725 million; NMV increased 34%… -
We hereby submit copies of the newspaper publications of the Un-audited Financial Results of the Company for the 1st qua…
Financial ResultsQ1FY27 results (unaudited): Standalone: Revenue and PAT not defensibly extractable Consolidated: Revenue and PAT not defensibly extractable FY26 res… -
Appointment of Independent Director
Management Change🎯 LEADERSHIP APPOINTMENT — Cyient Limited Muralidhar Yadama appointed as Independent Director Effective: 23-Jul-2026 -
General Updates
General UpdateKey Performance Indicators (KPIs) as defined in the Dec 2025 Prospectus are now uploaded on the company's website for investor reference. -
Tax Deducted at Source (TDS) on Dividend
Corporate ActionTax Deducted at Source (TDS) on Dividend - Company offers facility for submission of documents for lower or nil TDS rate - Shareholders must submit do… -
Newspaper Advertisement - Financial Results
Financial ResultsFY2026 results: Standalone: Revenue and PAT not defensibly extractable Consolidated: Revenue and PAT not defensibly extractable No reliable financial… -
Plese find attached Monitoring Agency Reports on the utilisation of proceeds raised through Qualified Institutions Place…
Regulatory ComplianceMonitoring Agency Reports for Q1FY27 on utilization of proceeds from QIP and Preferential Issue disclosed. Company raised Rs 550 crore via QIP and Rs … -
Amendment to AOA/MOA
Corporate ActionBoard approved amendment to Article 122 of Articles of Association to include nomination rights for Founders and significant investors, subject to mem… -
Outcome of Board meeting for the quarter ended 30 June 2026
Financial ResultsFY2026 results (audited): Standalone: Revenue 250.2bn +5.8% y-y (236.3bn) PAT 16.5bn +6.2% y-y (15.6bn) Consolidated: Revenue 726.8bn +9.0% y-y (666.… -
Press Release for Q1 financial results
Financial ResultsPress Release - Q1FY27 - Revenue 13.1bn +54% y-y; EBITDA 3.03bn (margin 23.1%), +49% y-y; PAT 1.81bn +45% y-y - BEV revenue grew 107% y-y, comprising … -
Audio Recording of Conference call in respect of Unaudited Financial Results for the quarter ended 30th June 2026
General UpdateAudio recording of Q1FY27 investors call uploaded -
Copy of Newspaper Publication published regarding Un-Audited Financial Results for the quarter ended June 30, 2026
Regulatory ComplianceNewspaper publication of un-audited Q1 FY27 financial results (routine disclosure, no material impact) -
Please find enclosed the proceedings of the Annual General Meeting held on Thursday, July 23, 2026.
General UpdateProceedings of 37th AGM held on July 23, 2026 via VC/OAVM - All Directors, CFO, and Company Secretary attended - Leadership changes noted: Makarand Pa… -
Audio Recording- Conference Call
General UpdateAudio recording of conference call on July 23, 2026 at 10:00 a.m. IST uploaded -
Listing of further issue of shares on preferential basis- Trading approval -equity shares
Corporate ActionListing of 14,294,072 equity shares issued on preferential basis upon conversion of warrants to Non Promoters approved and trading commenced from 23 J… -
Solara Active Pharma Sciences Limited has informed the exchange that there is no Deviation and Variation of funds raised…
Regulatory ComplianceNo deviation or variation in use of funds raised through Rights Issue for quarter ended June 30, 2026. - Total amount raised: Rs. 442.73 Cr - Rs. 438.… -
Grant of options under IGI Employee Stock Option Plan - 2024
Insider TradingGrant of 629,814 stock options approved under IGI Employee Stock Option Plan - 2024 - Options exercisable into equal number of equity shares of Rs. 2 … -
The Nomination and Remuneration Committee of the Board of Directors of the Company at its Meeting held on Thursday, July…
Insider TradingNomination and Remuneration Committee granted 1,96,721 stock options to eligible employees under ESOP Scheme X on July 23, 2026. -
Solara Active Pharma Sciences Limited has informed the Exchange regarding allotment of 2250 Equity Shares pursuant to ex…
Insider TradingAllotment of 2,250 equity shares under Solara Employee Stock Option Plan 2018. - Exercise price Rs. 375 per share; total money realized Rs. 8.44 lakh … -
Press Release on IEX Unaudited Financial Results for the Quarter ended June 30, 2026.
Financial ResultsPress Release - Q1FY27 - Electricity volume grew 15.9% y-y to 37.5 BUs - Consolidated revenue Rs 202.8 Cr, up 10.1% y-y - Standalone PAT Rs 126.7 Cr, … -
Investor Presentation
Financial ResultsAI summary - Q1 FY27 consolidated certification revenue grew 23% YoY to INR 3,598 Mn; EBITDA up 29% at INR 2,238 Mn - Consolidated PAT rose 31% YoY to… -
Please refer the enclosed intimation regarding the in-principle approval of the Board of Directors of the Company for ev…
Corporate ActionBoard approved in-principle evaluation of demerger of radiology business from wholly owned subsidiary Nueclear Healthcare Limited. Evaluation includes… -
Analysts/Institutional Investor Meet/Con. Call Updates
Financial ResultsPress Release & Investor Presentation - Q1FY27 - Operating PAT grew 14% YoY to ₹609 Cr; Total PAT ₹1,513 Cr - Asset Management PAT up 73% YoY; AUM gre… -
Press Release
Financial ResultsPress Release - Q1FY27 - Revenue 3,708 Mn +23% y-y; EBITDA 2,238 Mn +29% y-y; PAT 1,657 Mn +31% y-y - EBITDA margin 60%, +270 bps y-y; PAT margin 45%,… -
Financial Results for the quarter ended June 30, 2026
Financial ResultsQ1FY27 results (audited): Consolidated: Revenue 48.2bn +14.0% y-y (42.3bn) Operating profit 10.2bn +15.4% y-y (8.8bn) Operating margin 21.1% (20.8%) +… -
NACL Industries Limited has informed the Exchanges about the News Paper Publication.
Financial ResultsQ1FY27 results (unaudited): Standalone: Revenue 3.8bn -13% y-y (4.4bn) PAT 0.2bn -34% y-y (0.3bn) Consolidated: Revenue 3.9bn -14% y-y (4.5bn) PAT 0.… -
Submission of copies of Newspaper Advertisements confirming dispatch of notice of 14th EGM of the Company
Corporate Action14th Extraordinary General Meeting (EGM) Date: 13-Aug-2026 (Thu), 12:00 PM -
Press Release Q1 financial results
Financial ResultsPress Release - Q1FY27 - Revenue 13.1bn +54% y-y; EBITDA 3.03bn (margin 23.1%); PAT 1.81bn +45% y-y - BEV revenue grew 107% y-y, comprising 44% of tot… -
Board Approved unaudited financial results for the quarter ended June 30, 2026
Financial ResultsQ1FY27 results (unaudited): Standalone: Revenue 1.559bn +11.4% y-y (1.399bn) PAT 0.127bn +12.1% y-y (0.113bn) Consolidated: Revenue 1.579bn +11.4% y-… -
Please find enclosed herewith Unaudited Financial Results for the quarter ended June 30, 2026
General Update[Motilal Oswal Conference] Q1FY27 results (unaudited): Standalone: Revenue 58.3bn +22% y-y (47.0bn) PAT 24.7bn +17% y-y (21.1bn) Consolidated: Revenu… -
Investor Presentation
Financial ResultsAI summary - Q1 FY27 consolidated revenue 1,901m +7.9% y-y; EBITDA 465m (margin 24.5%); PAT 228m (12%) - Load factor improved to 105%, +5% vs Q1 FY26,… -
Outcome of Board Meeting held on 23rd July, 2026
Financial ResultsFY2026 results (audited): Standalone: Revenue 412.4bn +39% y-y (296.7bn) EBITDA 98.7bn +42% y-y (69.6bn) EBITDA margin 24.0% (23.5%) +50 bps y-y PAT 6… -
Newspaper Publications
Regulatory ComplianceNewspaper publication of un-audited Q1FY27 financial results (routine disclosure, no material impact) -
Copy of Newspaper Publication
Regulatory ComplianceNewspaper publication of un-audited Q1FY27 financial results (routine disclosure, no material impact) -
Copy of newspaper publication
Regulatory ComplianceNewspaper publication of unaudited Q1 FY27 financial results (routine disclosure, no material impact) -
Further updates on our earlier intimation dated January 29, 2026 and February 25, 2026.
Corporate ActionJoint Venture company Nichidai Sansera Private Limited allotted 8,000 equity shares to Nichidai Corporation. Post allotment, shareholding is 60% Sanse… -
Intimation w.r.t Investors meet
General UpdateInvestor/analyst meet scheduled for 03-Aug-2026 to 05-Aug-2026 in Edinburgh & London -
Investor Presentation for Q1 financial results
Financial ResultsQ1FY27 results (unaudited): Standalone and Consolidated combined: Revenue 13.1bn +54% y-y (8.5bn) EBITDA 3.0bn +49% y-y (2.0bn) EBITDA margin 23.1% (2… -
Please find attached the Investor Presentation on the Unaudited Financial Results (Standalone and Consolidated) for the …
Financial ResultsInvestor Presentation - Q1FY27 - Consolidated revenue grew 24.3% YoY to 240.0 Cr; PAT up 34.1% YoY at 51.3 Cr - EBITDA margin improved to 32.2% (+226 … -
Press Release - Q1 FY27 Results
Financial ResultsPress Release - Q1 FY27 - Gross Advances grew 22.0% y-y to ₹9,074 crore; Disbursements up 16.5% y-y to ₹1,009 crore - Total Deposits rose 16.3% y-y to… -
Attached
Regulatory ComplianceNewspaper publication of unaudited Q1FY27 financial results (routine disclosure, no material impact)
Never miss a filing again
1
Sign in with Google
2
Add stocks to watchlist
3
Get instant Telegram alerts
14-day Pro trial included · No credit card required
About this page.
Indian Stock Alerts monitors BSE and NSE for corporate announcements every few minutes.
Each filing is downloaded, parsed, and summarised by AI. This page shows the latest
processed filings across all 5,000+ listed companies. Data sourced from public SEBI LODR
filings. Not investment advice.
Browse all companies →